Estrella Immunopharma Stock Forecast
NASDAQ: ESLAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
Market open · Delayed 15 min · as of Oct 9, 11:46 AM ET
ESLA analyst consensus
Consensus
none
Avg. price target
$12.00+3012.84%
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
The average 12-month price target is $12.00, with a high estimate of $12.00 and a low estimate of $12.00. The average target implies upside of 3012.8% from the current price of $0.3855. The spread between the highest and lowest targets is 0.0%, a relatively narrow range.
Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for ESLA.
Summary generated from market data by MetaCap's automated system. Methodology
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $12.00 | +3012.84% |
| Average target | $12.00 | +3012.84% |
| High target | $12.00 | +3012.84% |